Amneal Pharmaceuticals (AMRX) Competitors

Amneal Pharmaceuticals (NASDAQ:AMRX) and Qiagen (NYSE:QGEN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Which has higher valuation and earnings, AMRX or QGEN?

Qiagen has lower revenue, but higher earnings than Amneal Pharmaceuticals. Qiagen is trading at a lower price-to-earnings ratio than Amneal Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amneal Pharmaceuticals	$2.85B	1.06	-$116.89M	$0.01	959.00
Qiagen	$1.98B	5.59	$83.59M	$1.69	29.42

Do institutionals and insiders have more ownership in AMRX or QGEN?

31.8% of Amneal Pharmaceuticals shares are held by institutional investors. Comparatively, 70.0% of Qiagen shares are held by institutional investors. 26.6% of Amneal Pharmaceuticals shares are held by company insiders. Comparatively, 9.0% of Qiagen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the media refer more to AMRX or QGEN?

In the previous week, Amneal Pharmaceuticals and Amneal Pharmaceuticals both had 11 articles in the media. Qiagen's average media sentiment score of 1.21 beat Amneal Pharmaceuticals' score of 1.12 indicating that Qiagen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amneal Pharmaceuticals	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Qiagen	8 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is AMRX or QGEN more profitable?

Qiagen has a net margin of 18.30% compared to Amneal Pharmaceuticals' net margin of 0.12%. Qiagen's return on equity of 14.77% beat Amneal Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amneal Pharmaceuticals	0.12%	-189.49%	6.17%
Qiagen	18.30%	14.77%	8.87%

Do analysts rate AMRX or QGEN?

Amneal Pharmaceuticals presently has a consensus target price of $11.60, indicating a potential upside of 20.96%. Qiagen has a consensus target price of $49.69, indicating a potential downside of 0.06%. Given Amneal Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Amneal Pharmaceuticals is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amneal Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Qiagen	0 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.27

Which has more risk & volatility, AMRX or QGEN?

Amneal Pharmaceuticals has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500.

Summary

Qiagen beats Amneal Pharmaceuticals on 8 of the 15 factors compared between the two stocks.